
    
      Depression is common in patients with acute CAS and increases cardiac morbidity and
      mortality. However, there are a few limited data available regarding the effects and safety
      of antidepressants for treating depression in patients with acute CAS. This study aims to
      investigate whether escitalopram might be an effective treatment option for these patients.
    
  